Does BOTULINUM TOXIN TYPE A Cause Contraindicated product administered? 455 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 455 reports of Contraindicated product administered have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 12.2% of all adverse event reports for BOTULINUM TOXIN TYPE A.
455
Reports of Contraindicated product administered with BOTULINUM TOXIN TYPE A
12.2%
of all BOTULINUM TOXIN TYPE A reports
435
Deaths
361
Hospitalizations
How Dangerous Is Contraindicated product administered From BOTULINUM TOXIN TYPE A?
Of the 455 reports, 435 (95.6%) resulted in death, 361 (79.3%) required hospitalization, and 363 (79.8%) were considered life-threatening.
Is Contraindicated product administered Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BOTULINUM TOXIN TYPE A. However, 455 reports have been filed with the FAERS database.
What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?
Off label use (1,785)
Drug ineffective (1,175)
Drug intolerance (1,004)
Product use in unapproved indication (950)
Headache (797)
Migraine (775)
Maternal exposure during pregnancy (716)
Pain (714)
Hypoaesthesia (703)
Nausea (665)
What Other Drugs Cause Contraindicated product administered?
ABATACEPT (13,559)
METHOTREXATE (13,121)
ETANERCEPT (12,062)
TOCILIZUMAB (11,547)
ADALIMUMAB (11,270)
LEFLUNOMIDE (11,206)
HYDROXYCHLOROQUINE (10,557)
RITUXIMAB (10,479)
INFLIXIMAB (9,618)
SULFASALAZINE (8,698)
Which BOTULINUM TOXIN TYPE A Alternatives Have Lower Contraindicated product administered Risk?
BOTULINUM TOXIN TYPE A vs BREMELANOTIDE
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN
BOTULINUM TOXIN TYPE A vs BREO ELLIPTA
BOTULINUM TOXIN TYPE A vs BREXANOLONE